Atlas Trials

Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia

Clinical trial NCT00780143 · TERMINATED

Trial details

NCT number
NCT00780143
Sponsor
PharmaMar
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed/Refractory Leukemia
Start date
2007-11-01
Primary completion
2009-06-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.